|
5471 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1653, 27.5.2017, Nr. 1, date:5.2017: 294
|
|
|
|
5472 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1663, 5.8.2017, Nr. 1, date:8.2017: 289
|
|
|
|
5473 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1664, 12.8.2017, Nr. 1, date:8.2017: 274
|
|
|
|
5474 |
Tocilizumab
Enthalten in Reactions weekly Bd. 1687, 3.2.2018, Nr. 1, date:2.2018: 205
|
|
|
|
5475 |
Tocilizumab: A Review in Rheumatoid Arthritis
Enthalten in Drugs Bd. 77, 1.11.2017, Nr. 17, date:11.2017: 1865-1879
|
|
|
|
5476 |
Tofacitinib reduces medical costs and risk of job loss in RA
Enthalten in PharmacoEconomics & outcomes news Bd. 778, 20.5.2017, Nr. 1, date:5.2017: 32
|
|
|
|
5477 |
Tracking low back pain in adolescent idiopathic scoliosis: a prospective cohort study protocol
Enthalten in Chiropractic & manual therapies Bd. 25, 5.9.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
5478 |
TRAIL gene 1595C/T polymorphisms contribute to the susceptibility and severity of intervertebral disc degeneration: a data synthesis
Enthalten in BMC musculoskeletal disorders Bd. 18, 29.12.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
5479 |
Transforming growth factor activating kinase 1 regulates extracellular matrix degrading enzymes and pain-related molecule expression following tumor necrosis factor-α stimulation of synovial cells: an in vitro study
Enthalten in BMC musculoskeletal disorders Bd. 18, 1.7.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
5480 |
Transient synovitis of the hip. Role of US, scintigraphy and MRI
Enthalten in Der Orthopäde Bd. 26, 1.10.1997, Nr. 10, date:10.1997: 858-867
|
|
Administration
